Financial Data and Key Metrics Changes - For the full year 2024, the company achieved $442 million in revenue, a year-over-year increase of nearly 40% compared to 2023, which was $321.2 million [23][24] - The gross profit for 2024 was $111.5 million, slightly down from $112.1 million in the prior year [24][26] - Net income for 2024 was $73.2 million, compared to $84.4 million in 2023 [23][24] - The company ended the year with an unrestricted cash balance of $671.4 million, bolstered by strategic initiatives and capital raises [28] Business Line Data and Key Metrics Changes - The Low Enriched Uranium (LEU) segment generated $349.9 million in revenue, an increase of $80.9 million compared to 2023, driven by growth in uranium and Separative Work Unit (SWU) revenue [24][26] - The Technical Solutions segment reported $92.1 million in revenue, an increase of $40.9 million compared to the previous year, with a gross profit of $17.6 million, up by $10.6 million [26][27] - The cost of sales in the LEU segment increased from $163.9 million in 2023 to $256 million in 2024, primarily due to higher average SWU and uranium costs [25][26] Market Data and Key Metrics Changes - The company’s total backlog reached $3.7 billion, with the LEU segment backlog at approximately $2.8 billion, including $800 million of future SWU and uranium deliveries [27] - The Technical Solutions segment backlog was approximately $900 million, which includes funded amounts, unfunded amounts, and unexercised options [27] Company Strategy and Development Direction - The company aims to restore America's ability to enrich uranium, focusing on domestic production to meet energy and national security needs [6][13] - Recent contract awards from the Department of Energy (DOE) are expected to support the restart of American uranium enrichment, reducing dependence on foreign sources [11][12] - The company is investing $60 million to resume centrifuge manufacturing and expand capacity at its Oak Ridge facility, reinforcing its first mover advantage [18][28] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing bipartisan support for nuclear energy and significant federal investments in domestic nuclear fuel production [30][33] - The company is positioned to capitalize on the growing demand for enriched uranium, especially with the upcoming ban on imports from Russia starting in 2028 [19][20] - Management emphasized the importance of public-private partnerships to support domestic enrichment capabilities and job creation [16][32] Other Important Information - The company has secured approximately $2 billion in customer contingent LEU sales commitments, indicating strong market demand [21] - The company has received approval for $62.4 million in investment tax credits for its manufacturing facility, contingent on meeting certain requirements [29] Q&A Session Summary Question: Follow-up on DOE contracts and task orders - Management indicated that while there is forward movement on task orders, they cannot speculate on timing [35][36] Question: Details on the $60 million investment - The investment is aimed at readiness and preparation for upcoming task orders, ensuring the company can respond quickly [39][40] Question: High uranium sales in Q4 - The high revenue was attributed to taking advantage of market opportunities rather than selling inventory [46] Question: Timeline for the first commercial cascade - The $60 million investment officially starts the 42-month timeline for bringing on the first commercial cascade [51] Question: Investment tax credit details - The company explained that the investment tax credit can be realized over approximately four years, contingent on meeting specific conditions [57]